Other OTC - Delayed Quote • USD
PharmChem, Inc. (PCHM)
At close: April 25 at 3:25 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Thompson Clark CPA | Interim CEO & Director | -- | -- | -- |
| Shana Veale | CFO, VP & Controller | -- | -- | -- |
| Kerri Wagner | Chief Revenue Officer | -- | -- | -- |
PharmChem, Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.
Corporate Governance
PharmChem, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Feb 15, 2023Dividend Date
- Feb 07, 2023Ex-Dividend Date
Upcoming Events
Apr 26, 2024 - Apr 27, 2024
PharmChem, Inc. Earnings Call